NKTREUR Nektar Therapeutics

held by 1 manager in Q4 2017

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	5.52%	1.0 yr	Add 57.3%	$110M	1,834,000

Search